Contract Pharma Manufacturing White Papers & Articles
-
The Changing Landscape Of Oncology Drug Development
5/17/2022
Discover the guidance for navigating unique formulation and handling requirements, novel trial designs and supply chain implications, and regulatory and clinical strategies to support product approvals.
-
Accelerating The Development Of Orphan Drugs For Rare Diseases
4/18/2022
Explore four principal CMC challenges for the developers of orphan drugs and the potential emerging solutions.
-
Trends In The Outsourcing Of Development And Manufacturing Of Biologics
3/18/2022
Read more on trends related to outsourcing and share what attributes of an outsourcing partner are sought by developers and manufacturers of biopharmaceuticals.
-
A Molecule’s Journey: Achieve Commercial Manufacturing Success
3/18/2022
Experts share what they consider to be key considerations for biopharmaceutical companies as they advance to commercial manufacturing and navigate complex processes.
-
Lyophilization vs. Liquid Formation: Why Lyo Offers Advantages
3/8/2022
Lyophilization offers some alluring advantages in today’s complex market, but its challenges require innovation and expertise to surmount.
-
Accelerating The Development Of Oncology Medicines
3/3/2022
Oncology drug development has seen a significant shift in focus, as molecule chemistries and drug technologies have improved. Explore five areas for consideration and the potential emerging solutions.
-
Strategies For Accelerating The Development Of Modified Release Oral Forms
3/3/2022
Careful selection of appropriate excipients and delivery technologies is key to the design of modified release (MR) formulations fulfilling specific performance requirements.
-
Nanosuspension Dosage Forms: Product Development & Scale Up
2/8/2022
For drug nanosuspensions, parameters like stabilizer concentration, drug loading, milling speed, milling time, bead diameter/density, and temperature are important formulation and process variables.
-
Considerations In Formulation Development Of Injectable Solutions
2/8/2022
Injectable solutions offer an alternative to oral dosage form due to fast onset, reproducible PK/efficacy profile, high bioavailability, and suitability of administration under hospital setting.
-
Variables Impacting Cell And Gene Therapy Development Success
2/3/2022
Explore four key interconnected variables exerting pressure on therapeutics developers to improve their processes earlier in the product’s development.